Immunomedics, Inc. (IMMU) Reports Q1 EPS Loss of $0.10, Misses Consensus by 2c
Immunomedics, Inc. (NASDAQ: IMMU) reported Q1 EPS ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)